What Is Assisted Hatching — And Does the Evidence Support It? (2026)

Assisted hatching is a laboratory step in which the outer shell of the embryo, the zona pellucida, is thinned or breached before transfer — usually with a laser. The intention is to help the embryo break out of that shell and implant.

It is an add-on. It is not part of a standard IVF or ICSI cycle, and it is almost always priced separately, which is why it tends to appear as a line item on a treatment estimate rather than in the main conversation.

• Assisted hatching is a paid add-on, not part of a standard IVF or ICSI cycle.
• A Cochrane review of 39 randomised trials in 7,249 women found uncertain effects on live birth: OR 1.09, 95% CI 0.92 to 1.29.
• Only 14 of the 39 trials reported live birth, and evidence quality was rated very low to low.
• Assisted hatching may slightly increase multiple pregnancy rates, which carries higher risk for mother and babies.

The technique is usually described as laser-assisted hatching when a laser is used, which is now the most common method.

The reasoning is that some embryos fail to implant because they cannot escape the zona pellucida, and that thinning it removes a mechanical obstacle. It is most often proposed after failed cycles, at older maternal age, or where the shell looks thick.

This is a coherent hypothesis, and it is worth saying so. Assisted hatching is not arbitrary — there is a plausible mechanism behind it. The question is whether the mechanism translates into more babies, which is an empirical matter rather than a logical one.

It is frequently offered after recurrent implantation failure, where the wish to change something about the next cycle is strongest and hardest to argue with.

The evidence is uncertain. A Cochrane review of 39 randomised trials in 7,249 women found we cannot be confident whether assisted hatching improves live birth, with an odds ratio of 1.09 and a confidence interval from 0.92 to 1.29 across the 14 trials that reported live birth at all.

Two details in that sentence carry most of the weight. The confidence interval crosses 1.0, meaning the data are compatible with a small benefit, no effect, or a small harm. And only 14 of 39 trials reported live birth — the outcome that matters — at all.

Cochrane rated the quality of evidence from very low to low, citing serious risk of bias from poor reporting of study methods, inconsistency, imprecision and publication bias. That is about as heavily qualified as a conclusion gets.

So the honest position is not that assisted hatching does not work. It is that after 39 trials and more than 7,000 women, we still do not know — and a technique in routine paid use might reasonably have been expected to have settled the question by now.

The gap between 39 trials and 14 reporting live birth is itself worth pausing on. Trials that report clinical pregnancy but not live birth stop measuring before the outcome patients actually care about.

Pregnancy that does not continue is not what anyone is paying for, and a literature that reports the earlier measure more often than the later one is easier to read optimistically than it deserves.

Publication bias, which Cochrane names explicitly, compounds this. If studies showing a benefit are more likely to be written up and published than those showing nothing, the visible literature is more favourable than the real one — which means the true effect, if any, is more likely to sit at the lower end of that confidence interval than the upper.

One is documented. The same Cochrane review found that assisted hatching may slightly increase multiple pregnancy rates compared with no assisted hatching.

Multiple pregnancy is not a benign outcome. It carries higher risks for both mother and babies, and reducing it is a stated aim of modern practice. A step that may raise it without demonstrating a rise in live birth is a poor trade on the evidence as it stands.

The review's own conclusion puts it directly: the risks associated with multiple pregnancy may be increased without evidence of an increase in live birth rate, which warrants careful consideration of routine use.

The proposed explanation is that hatching may improve the chance that a given embryo implants without improving the chance that the cycle ends in a live birth — so where two embryos are transferred, both are somewhat more likely to take. That would raise multiples without raising live births, which is close to what the data show.

If that is right, the practical response is not necessarily to decline hatching. It is to consider it alongside the number of embryos transferred, since the combination is what carries the risk. A single embryo transfer changes the calculation substantially.

That is a decision for you and your clinician, but it should be made with the evidence stated accurately. On current evidence, assisted hatching has not been shown to improve live birth, and may slightly increase multiple pregnancy.

• Live birth: uncertain, OR 1.09 (95% CI 0.92 to 1.29), low-quality evidence.
• Only 14 of 39 randomised trials reported live birth at all.
• Evidence quality rated very low to low by Cochrane.
• May slightly increase multiple pregnancy rates.

If it is being recommended for you specifically, ask what about your case makes it likely to help — and whether the clinic has its own outcome data for patients like you. A specific answer is more useful than a general one, and either is more useful than the add-on appearing on an invoice without discussion.

There is a wider point about add-ons that applies well beyond this one. IVF has accumulated a long list of optional extras, each with a plausible mechanism and a separate price, and the burden of proof tends to sit in the wrong place.

The default assumption is often that an add-on probably helps a little and cannot hurt, when the evidence frequently supports neither half of that.

A reasonable position is to ask of each item what it would take to convince you it worked, and whether that evidence exists. For assisted hatching, after 39 randomised trials, it does not yet — which is a more useful thing to know than any individual opinion about the technique.

The most useful question is simply what evidence the recommendation rests on. Assisted hatching is old enough and studied enough that a clinic recommending it should be able to say why in your case.

• What specifically about my embryos or history makes hatching worth doing?
• What does it add to the cost?
• What does the clinic's own data show for patients in my situation?
• How does this interact with the number of embryos being transferred?

That last question matters given the multiple pregnancy finding. If assisted hatching may slightly raise the chance of a multiple, it is worth discussing alongside how many embryos are being transferred rather than as a separate item. Our page on blastocyst culture and transfer covers the wider transfer decision.

If the answer to any of these is that assisted hatching is simply what the laboratory does as standard, that is worth knowing too. It is not necessarily wrong — a laboratory practised at a technique may get better results with it than one that performs it occasionally — but it is a description of the clinic's routine rather than a finding about your embryos, and you are entitled to know which you have been given.